Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001193805-25-001212 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-19 | 2025-08-15 | ARCT | SASSINE ANDY | CFO, Dir | P - Purchase | $16.56 | -1,238 | 221.8K | -0.6% | -$20.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | P | D | 1,238 | $16.56 | 221,764 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025. |